Ultragenyx Pharmaceutical Company
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Investors
Technology:
Immunotherapy
Founded Date:
2010
Headquarters:
Novato, California, United States
Employee Number:
501-1000
Estimated Revenue:
$10M to $50M
Funding Status:
IPO
Industry:
PharmTech








%20.jpg)





%20.jpg)


